SEC Form 3 · accession 0001193125-26-386778
Kailera Therapeutics, Inc. · KLRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nur Nicholson
Officer — Chief Technology Officer
Period of report
Aug 31, 2026
Accepted (ET)
Sep 9, 2026 · 7:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0002096997
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
No Table II lines on this filing.
Remarks
Exhibit 24 - Power of Attorney